World’s First AI-Powered Cardiovascular Retinal Screening to be Launched in the UK

Heart Eye has unveiled AI-powered cardiovascular screening technology using retinal imaging in the UK. The company says the technology delivers patients’ cardiovascular disease risk results in just 3 minutes.

The technology, called 'Dr.Noon CVD,' is being launched in the UK by Husain Khaki, MD, and will debut at two major optical conferences: 100% Optical at ExCeL London and the Optix Conference 2025 at Celtic Manor.

Dr.Noon CVD analyses retinal vessel images with advanced artificial intelligence noninvasively, and autonomously predicts future cardiovascular risks, providing real-time scores without blood sampling or radiation.

According to Heart Eye, Dr.Noon CVD is the first retinal-based AI tool capable of assessing cardiovascular risk with the same accuracy as heart CT scans.  Patients avoid blood tests and radiation exposure, while clinicians receive accurate results in minutes. Heart Eye says in the future, the technology will also be capable of performing noninvasive assessments for other organs including kidney function.

"Conventional heart CT scans expose patients to high-dose radiation and are confined to secondary care, come with high costs, and deliver slow results. Carotid ultrasounds are time-consuming, less precise, and more expensive than retinal imaging," the company stated in a news release. "Dr.Noon CVD’s deep-learning algorithm enhances CVD risk stratification, validated on a global cohort, and matches the predictive performance of heart CT scans. Its scalable, cost-effective design enables broader access to life-saving diagnostics."

“It’s easy to use in hospitals, opticians and primary care settings, giving patients a quick, non-invasive and radiation-free way to get results. DrNoon CVD solves the problem of late diagnoses and makes it easier for more people to access the care they need – ultimately changing the way we approach cardiovascular health around the world," Dr. Khaki said.

Heart Eye will be offering free cardiovascular disease risk retinal scans using Dr.Noon CVD at the following exhibitions:

• 100% Optical: March 1-3, 2025 at London’s ExCeL

• Optix Conference: March 17-19, 2025 at The Celtic Manor